XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statement of Earnings (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net sales $ 10,635 $ 10,143 $ 30,976 $ 29,868
Cost of products sold, excluding amortization of intangible assets 4,698 4,605 13,764 13,419
Amortization of intangible assets 470 496 1,413 1,485
Research and development 713 672 2,095 2,041
Selling, general and administrative 2,895 2,723 8,790 8,225
Total operating cost and expenses 8,776 8,496 26,062 25,170
Operating earnings 1,859 1,647 4,914 4,698
Interest expense 142 166 423 478
Interest (income) (91) (97) (253) (296)
Net foreign exchange (gain) loss (11) (10) (17) 17
Other (income) expense, net (121) (83) (222) (370)
Earnings before taxes 1,940 1,671 4,983 4,869
Taxes on earnings 294 235 810 740
Net Earnings $ 1,646 $ 1,436 $ 4,173 $ 4,129
Basic earnings per common share (in dollars per share) $ 0.94 $ 0.82 $ 2.39 $ 2.36
Diluted earnings per common share (in dollars per share) $ 0.94 $ 0.82 $ 2.38 $ 2.35
Average number of common shares outstanding used for basic earnings per common share (in shares) 1,739,466 1,738,700 1,740,869 1,740,255
Dilutive common stock options (in shares) 8,131 9,589 8,565 9,819
Average number of common shares outstanding plus dilutive common stock options (in shares) 1,747,597 1,748,289 1,749,434 1,750,074
Outstanding common stock options having no dilutive effect (in shares) 6,905 7,334 6,892 5,474